Net profit of Gufic BioSciences declined 6.16% to Rs 21.78 crore in the quarter ended September 2024 as against Rs 23.21 crore during the previous quarter ended September 2023. Sales declined 4.98% to Rs 204.18 crore in the quarter ended September 2024 as against Rs 214.87 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales204.18214.87 -5 OPM %18.9218.32 - PBDT33.5735.24 -5 PBT29.2730.94 -5 NP21.7823.21 -6 Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Gufic BioSciences announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live News

Net profit of Gufic BioSciences rose 1.16% to Rs 20.86 crore in the quarter ended June 2024 as against Rs 20.62 crore during the previous quarter ended June 2023. Sales rose 3.99% to Rs 202.81 crore in the quarter ended June 2024 as against Rs 195.02 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales202.81195.02 4 OPM %17.6518.19 - PBDT32.4232.29 0 PBT28.1128.05 0 NP20.8620.62 1 Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live News